Blazer II Cardiac Ablation System and Cable
Boston Scientific Corp · Decision date Aug 14, 2025
What did the FDA approve?
FDA records P920047/S137 as a supplement to PMA P920047, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 14, 2025.
FDA approval order statement
for a manufacturing site located at Boston Scientific de Costa Rica, S.R.L., El Coyol Alajuela, Coyol, Costa Rica (FEI: 3007695959) to perform ethylene oxide sterilization activities
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 14, 2025
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P920047/S137
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- LPB
- Decision code
- APPR
- Decision date
- Aug 14, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Cardiac ablation percutaneous catheter.
- Applicant
- Boston Scientific Corp
- Product code
- LPB
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P920047/S137 received
Application receipt date recorded by FDA.
P920047/S137 · FDA decision
Normal 180 Day Track No User Fee
P920047/S138 · Related supplement
RHYTHMIA HDx Ablation Connection Box (for INTELLAGEN) (M004RA65010)
Timeline entries are records held by MedtechLedger for P920047. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P920047
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Boston Scientific Corp | PMA supplement | Oct 17, 2025 | FDA |
Explore the linked device profile
Other records with product code LPB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
| Irvine Biomedical, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
Ampere GeneratorP040014/S051 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP960016/S094 | St Jude Medical | PMA supplement | Aug 7, 2026 | FDA |
MAGiC Ablation CatheterP240014/S001 | Stereotaxis, Inc. | PMA supplement | Jul 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P920047/S137
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


